<SEC-DOCUMENT>0001104659-13-037095.txt : 20130503
<SEC-HEADER>0001104659-13-037095.hdr.sgml : 20130503
<ACCEPTANCE-DATETIME>20130503153333
ACCESSION NUMBER:		0001104659-13-037095
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20130502
FILED AS OF DATE:		20130503
DATE AS OF CHANGE:		20130503

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CELESTICA INC
		CENTRAL INDEX KEY:			0001030894
		STANDARD INDUSTRIAL CLASSIFICATION:	PRINTED CIRCUIT BOARDS [3672]
		IRS NUMBER:				980185558
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14832
		FILM NUMBER:		13812428

	BUSINESS ADDRESS:	
		STREET 1:		844 DON MILLS ROAD
		CITY:			TORONTO
		STATE:			A6
		ZIP:			MC3 1V7
		BUSINESS PHONE:		416-448-5800

	MAIL ADDRESS:	
		STREET 1:		844 DON MILLS ROAD
		CITY:			TORONTO
		STATE:			A6
		ZIP:			MC3 1V7
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a13-11522_16k.htm
<DESCRIPTION>6-K
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div>
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;6-K</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Report of Foreign Private Issuer</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Pursuant to Rule&nbsp;13a-16 or 15d-16</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">under the Securities Exchange Act of 1934</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">For the month of May, 2013</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">001-14832</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Commission File Number)</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">CELESTICA INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Translation of registrant&#146;s name into English)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">844 Don Mills Road</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Toronto, Ontario</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Canada M3C 1V7</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(416) 448-5800</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive offices)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form&nbsp;20-F or Form&nbsp;40-F:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form&nbsp;20-F </font><font size="2" face="Wingdings" style="font-size:10.0pt;">x</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form&nbsp;40-F </font><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indicate by check mark whether the registrant is submitting the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(1):&nbsp;</font><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indicate by check mark whether the registrant is submitting the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(7):&nbsp;</font><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105918\13-11522-1\task6022020\11522-1-ba.htm',USER='105918',CD='May  3 21:04 2013' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Celestica Inc.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following information filed with this Form&nbsp;6-K is not incorporated by reference in Celestica Inc.&#146;s registration statements, the prospectuses included therein, or any registration statement subsequently filed by Celestica Inc. with the Securities and Exchange Commission:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Press Release, dated May&nbsp;2, 2013, the text of which is attached hereto as Exhibit&nbsp;99.1 and is incorporated herein by reference.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibits</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">-</font></p>    </td>
<td width="93%" valign="top" style="padding:0in 0in 0in 0in;width:93.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press   Release, dated May&nbsp;2, 2013</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2<a name="PB_2_205207_7056"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\105918\13-11522-1\task6022020\11522-1-ba.htm',USER='105918',CD='May  3 21:04 2013' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SIGNATURES</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CELESTICA INC.</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:   May&nbsp;3, 2013</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BY:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;/S/   ELIZABETH L. DELBIANCO</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Elizabeth L. DelBianco</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief Legal Officer</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3<a name="PB_3_205309_5335"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\105918\13-11522-1\task6022020\11522-1-ba.htm',USER='105918',CD='May  3 21:04 2013' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">EXHIBIT&nbsp;INDEX</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">-</font></p>    </td>
<td width="93%" valign="top" style="padding:0in 0in 0in 0in;width:93.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press   Release, dated May&nbsp;2, 2013</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4<a name="PB_4_205324_5796"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\105918\13-11522-1\task6022020\11522-1-ba.htm',USER='105918',CD='May  3 21:04 2013' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a13-11522_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.1</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="164" height="77" src="g115221mmi001.gif"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.68%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">FOR IMMEDIATE RELEASE</font></b></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Thursday, May&nbsp;2, 2013</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Celestica Now Certified to ISO 13485 for Medical Device Manufacturing in Romania</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TORONTO, Canada - Celestica Inc. (NYSE, TSX: CLS), a global leader in the delivery of end-to-end product lifecycle solutions, is pleased to announce that its Oradea, Romania facility is now certified to ISO&nbsp;13485.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ISO&nbsp;13485&nbsp;is an internationally recognized quality management system (QMS) standard for the medical industry. It requires strict adherence to quality and reliability standards in healthcare, including corrective actions to drive consistency for medical devices.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;This is an important milestone for Celestica as we extend our medical device manufacturing and engineering services in Europe, strengthening Celestica&#146;s&nbsp;global supply chain network,&#148; said Kevin Walsh, Vice President, Celestica HealthTech. &#147;This certification is a further demonstration of Celestica&#146;s ongoing commitment to make investments to achieve&nbsp;market-leading quality and regulatory compliance&nbsp;for our global healthcare customers.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Oradea, Romania facility is one of Celestica&#146;s ISO&nbsp;13485-certified Centers of Excellence for medical manufacturing, joining Portland, OR, United States; San Jose, CA, United States; Galway,&nbsp;Ireland; Valencia, Spain; Suzhou, China; Johor Bahru, Malaysia; and Serangoon, Singapore.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition to ISO&nbsp;13485&nbsp;certification, Celestica is also fully qualified to meet other rigorous standards of the medical industry around the globe, such as ISO 9001,&nbsp;ISO 14001, Class&nbsp;7 Clean Rooms, FDA-registered sites, robust cGMP and QS processes, and QSR/cGMP-compliant facilities.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About Celestica</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Celestica is dedicated to delivering end-to-end product lifecycle solutions to drive our customers&#146; success. Through our simplified global operations network and information technology platform, we are solid partners who deliver informed, flexible solutions that enable our customers to succeed in the markets they serve.&#160; Committed to providing a truly differentiated customer experience, our agile and adaptive employees share a proud history of demonstrated expertise and creativity that enhances our customers&#146; ability to overcome complex challenges.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For further information on Celestica, visit its website at www.celestica.com.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105918\13-11522-1\task6022020\11522-1-mm.htm',USER='105918',CD='May  3 20:55 2013' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About Celestica HealthTech</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Celestica HealthTech works with medical device companies to help them bring innovative technologies to market faster and more efficiently. We collaborate with our customers to improve patient care through innovative thinking and advanced technical expertise. Our manufacturing, supply chain and after-market solutions accelerate product development and rapid delivery of quality healthcare technology.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For further information on Celestica HealthTech, visit its website at www.celesticahealthtech.com.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Celestica Safe Harbour and Fair Disclosure Statement</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Statements contained in this news release that are not historical facts are forward-looking statements. Such forward-looking statements include, without limitation, statements regarding management&#146;s plans to expand device manufacturing and engineering services in Europe; the anticipated impact of such expansion on the company&#146;s supply chain network; potential investments in the healthcare business segment; and the intended benefits of such investments for our healthcare customers. Such forward-looking statements are predictive in nature and are based on current expectations, forecasts or assumptions involving risks and uncertainties that could cause actual outcomes to differ materially from the forward-looking statements themselves. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the U.S. Private Securities Litigation Reform Act of 1995, and in applicable Canadian provincial and territorial securities legislation. Forward-looking statements are not guarantees of future actions, events or outcomes.&#160; Persons reading this news release are cautioned that factors that could cause actual events or results to differ materially from those suggested in these forward-looking statements include, but are not limited to, regulatory, design, engineering, intellectual property, technological and competitor risk and the other industry-specific and company-specific risks, uncertainties and factors identified in our various public filings at www.sedar.com and www.sec.gov including our Annual Report on Form&nbsp;20-F and subsequent reports on Form&nbsp;6-K filed with the U.S. Securities and Exchange Commission and our Annual Information Form&nbsp;filed with the Canadian Securities Administrators. Forward-looking statements are provided for the purpose of providing information about management&#146;s current expectations and plans relating to the future.&#160; Readers are cautioned that such information may not be appropriate for other purposes. Except as required by applicable law, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Contacts:</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Celestica Global Communications</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(416) 448-2200</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">media@celestica.com</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105918\13-11522-1\task6022020\11522-1-mm.htm',USER='105918',CD='May  3 20:55 2013' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g115221mmi001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g115221mmi001.gif
M1TE&.#=AI`!-`'<``"'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"P`
M````I`!-`(?____O[^_F$"'F"!`0&1GF.D+F<X3FI:6U[\7F0HRU0HSF$(RU
M$(RU<\[F<\Y::UH0&4(02EKF[UKF[Y3F:RFU[UJU[Y2U:RE:*5K%Q<6$2EKF
M:PBU:PA:"%KFC%JUC%JMI:4A(2'F8VLQ&3J,K=Z,K5HZK=XZK5J,&>\Z&:V,
MK9R,:QF,*92,[YR,[QDZ*=XZ[YPZ[QF,K1DZK9PZK1F,*1DQ:QEC6N\06JUC
M&>\0&:UCK9QC:Y1C[]YC[UH0:]X0[]X0[UICK=YCK5H0K=X0K5IC*91C[YQC
M[QD0*=X0[YP0[QECK1D0K9P0K1D0:QF,2I2,SMZ,SEHZ2MXZSMXZSEJ,C-Z,
MC%HZC-XZC%J,2AF,")2,SIR,SADZ"-XZSIPZSAF,C!DZC)PZC!F,"!ECC)QC
M2I1CSMYCSEH02MX0SMX0SEICC-YCC%H0C-X0C%IC")1CSIQCSAD0"-X0SIP0
MSAECC!D0C)P0C!D0"!#F8TKF*2GOQ<6UG(SFI>^UI>\I"!#F0N_F0JWFG"FU
M0JVU0N_F$*VU$*WF<Z7F$.^UG"FU$.^U<Z6U<^_F<^_F0L[FG`BU0L[F$,ZU
MG`BU$,ZU<X2U8TKFUN\Q:UHQ&6.,*5H0&6,0:UJ]SN^,"%JM.AFM$!D("`#F
M.F/FK5JUK5KFG(0Q0E*UI<7FI<6U.F/F$&.U$&/FSBFUSBFU.D+F$$*U$$+F
MS@BUS@CO,0CFSDKFSH2USDJUSH3>YLZMQ<6,C(R,C*6][^^U8VO..AG.$!G6
MQ<7OYL5:2F-[:VN,:Z6,:\XZ:XR,*<XZ*8QC:\X0:XQC*<X0*8P02BDQ.C&,
M2LXZ2HR,",XZ"(QC2LX02HQC",X0"(P02@@I(1#F[RFU[RE::RE:*2E:2BE:
M""GF[PBU[PA::PA:*0A:2@A:"`B$:TI22DH0&0CFSFOFSJ6USFNUSJ6$:WN,
M[^^,:^^,[VLZ:^\Z[^\Z[VLZ:ZTQ0A",[\Z,2N^,[THZ:\XZ[\XZ[THZ2JWW
M$"'W"`C_WN___^\(_P`!"!Q(L*#!@P@3*ES(L*'#AQ`C2IQ(L:+%BQ@S:MS(
ML:/'CR!#BAQ)LJ3)DRA3JES9\%(P/C#]!6!)LZ9$?P<,%-C#3X!/`7L*&#@P
MTZ;1HP+YB-C3;\`>`?QX1AW`;P#04I>0:E5Y282``0,*+(T*M*<>GD_[[1&1
M=:M;D0=F61T@X@!/J$SWZ"SKLVD!/F\#=T1DM6<I?Z)ZWMUSP.MB?CO!EA),
M^2*?/589`Q"AEF=8/@;ZD>4WZ]78KP8JJY:HA^I?``<R5RV`\RG:`:)*H7TZ
M(/7JWPL)"Q#Q#\#EJ%5%^..#=ZJ>`SV18Q9P`+AU@\&>3@:`F"IFY0'R]O_L
M)X*/*+ZW!0"[SCZ`J#VH!K;V/#F`'I]3#?@K('H/6JBDB5(<>\"54D`P`]G5
MDP#;B>!=5:F),`MR?,URW@#5$;C:)?H-!(Q/5*4C$&%/184(``8,\(IM4ZVU
M4S\%:*C:/Y<4!8![W@$&`"K^\5-5=78YI59/$R+2&E`"V"AC8`,*Y&!8;5W6
M#U![`!:;C_Y!)4`!J'!VFXY+JA;;`'KX4QR.KTR("HUY]3@;'Z4\")5O85(&
MS'?^"&0?5:5EY<]_BM'U3VADH:5'G92YUP^=`)0"%6X(^G,D6A#"YA2%>ZR8
M)Z)N!<!9A@(=`*)R3CZ(F697(@FC`?Z!R2E2HH+_:AQO(A1%8E0E`BG`D$S5
ME9:KK](TTV6NXE*`508,&!=?,.;)'(7\&'#<4[(&*ZP(ZPWDWE?;&><36OV(
MDI64GE&WGY;\5&NM2@$<T-9`H5$W$"Z8(=?;/_]DA^26?/QS+*X#`+MN2@$$
MT*2EFNE90',,SG3)PCS!F)6#/4(E\,`T`>,4F/;AY52&`?S;4[*;75KB'IMB
MS-),-`(%6%$&1!=5?-QYZ=-V<=X5U4X'J[Q2R'N\"X!P58F2,L51Z4@8ED[I
MQ*C/*XE0@(T!I'.J`'H4+%"<7XGRLM6*P0A:/^I"31+,61/$QRM4"<`HU^1M
MNK935HDP])0IFXU28T4Y_\S?502):IA`-*995;K>SK*'WBH!@\C!(6=&<ZA@
M)7SCJ60"=@E3PS%^$HU\*+G9KJ\-=-EGVMX'5:T`^#MET)Z?I#5!*=*5]YVV
M:^N@6I-33';L-,5%%]6;]Z9D[5XG."KP+*%BU8D$A2<O020RJC%593-/$KT8
M%@0TL+%9SAU3>@BMO4F;5^F]'J*(S@>9>8>7<,_GCW26^9ZRKK9>HHM0OK;U
M&\E,/-4^[Y6B6QX2A;H.0)0`IJ04^M/6`28WD$M@Y2"B<R!)#@"]@N!"8`'@
M0]XTR!(^9,M[)*Q,!E/(PA:Z\#>X6.$+"8*+7>A"%[A8"2[8X8Q.T&]@EUB'
M#?]UL8L,R'`A&<A#*/*0@93\HQ/.R`,@F@BU##S`&8#(PSFV"`AGL".'$,E`
M"`@0`BJ"9!?KN!%!DDA&,&(L`+H(@10)H,4\V)&.90QC"+"1QX[,!!</",4N
M#)(!;.0!&YU0X[H"\(`Y$L`9#V"'+JXH1V>XL2%B#$$?_1A%0("`D,[`H<]T
M<4@RZD))`5B'.4X1D4P2P(P<"<`(QCA([QV14TD<HS-@&3V$%&QV:PP!(#89
MO0#42"$%B^%!]@B(-$K$F$<,`"Z.^99&\O&3#[&B.4+@#'.<<HW.(",O,S",
M;79S%Y<4"#F=,0)GF&(8()A)+H81QS&:0Y+#J.4EZ/G_1>_MPAS.X*8YT*FM
M75PQH.>\94IPH<D\/.`A<+1C*):X1'.X48Q\A*4NZ#C1<RS1&=0$P"X,J<2)
MVE$7`!#&1/DX1H^&PASJ-&DB![*.$6S1CEH,Q2X!T`ENU%&)=WR`0D]RBF$2
M`)L-(:4<S3&,*]K1&44!QA@W24HZOG,84<P#5-4I1P*80I+"B&(3JSI&/I(Q
M#^:8B1@)@`TSGD*.ANSF-O,P@AP&((HA8.H#MFE(E!Y%%Z'09#H3PL80^!4`
MN`AH'FJ9R3YBE`"Z&!`NS$''6NKB'-A(Z[RHB(L,@""@(1A&!D8+1HR&`(R)
M/:0S=F$PQ+(C%P/)@"@'\H"E_R+E`03HHOD2@EM`/)0@I\`&`6"*6&'VL:K$
MC>T>G5$<W*)U(8I%JG+%*1"E'C4BE]#E;E<RC#QP<Z@W&@$?9ZJM/89`K5-M
MXEV'R<L`:#($62&E<(<Q6(%D=XS2Y2H?LW+70P[#(=(<K2[B"EZ2#,.0I\7D
M>Q^@BV$XN,'I!4!CF\A033Z`GCP8!CN&(=Y7%M>[9!2M0>Z*#4"H@)!EI7!#
M88M$K,K1CGRLZU%VX5ULL)(A2>3C1"FZQ-QZV+1-?*Q$39H'.A+`F1F((@&,
M_`"AN1>_*!XO`(+;1F0Z]X[O?62!1Y(!MA+@OSA^;S?=Z8PR`]04*M9DD,5,
M9C(#U/\<9L2%+I2<Q9WJ*9S8J&4PV9J!?TQ8(:0$Q)=!D`%<@."]6Q;)DQ]9
MWX)T>;\SV=0`!R1&]A97DY?X1Y[^,4!@5O"S#05S>`V97PF;-X<9$'0(;HS!
M]TH7HUO]JW?1JM"[RK'4!>E$A`-@CD/J^2'F(/"=A5OJ/Y/8H0EAZ",=/=7M
MZA"+]APL.;'976R8(H,V*J2:!=)=+8\8T-Z-M7N7_&MU"A>^W":CB6UI:FS$
M6K];#4`&3E%H8S9:)&N58P@>L`L0@&"2E<PA0^,*@AH9^@'"\-![.>L,@L<0
M%Z?8ZT!.80X0X(+32;;M0$P!"'<7>K3Z[6-J-2G:SOXSK7?S)>,#8A@`$&R3
MC$51P0,R8`Y@E$'4*!'CK._X4SK>>!=L+3(W7\Q$KEI:("#PL58;:L=/WG6)
MW%3LM@<RC"5G4>,Z3S#2Z6A(,LK1HX-4:KCE&-@N%N42IV0P/5F"BV$(DP#G
M$+0=\VK$V$9QB^>8.YS5N>2B#R07O<Z[%LFX]P!@%:=V/,=JO=?(<]#1NZ@N
MLM_525F<;G'?ZNVNY4=0VR*W)0!?W`4]O\EV%91SK\-007U;/@QA7%CUT?-W
M/+T'@J9>F*`T%#WJ=X$@@_C#].9@<-U;[N\,_AOA^1RG@_.90R$Z\T8/GR8O
+9TC]ZEO_^@$!`#L_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
